{
    "2020-04-29": [
        [
            {
                "time": "2020-04-30",
                "original_text": "Novartis International AG (NVS) Q1 2020 Earnings Call Transcript",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Earnings",
                        "Q1",
                        "Transcript"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-30",
                "original_text": "Biotech Stocks Earnings Roster for Apr 30: AMGN, GILD & More",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Earnings",
                        "AMGN",
                        "GILD"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-30",
                "original_text": "Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cosentyx",
                        "European",
                        "approval",
                        "$5 billion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}